Immunic, Inc. (IMUX)

USD 1.03

(-5.5%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 111 Thousand 77 Thousand 85 Thousand 39 Thousand 50 Thousand 15 Thousand
Gross Profit -111 Thousand -77 Thousand -85 Thousand -39 Thousand -50 Thousand -15 Thousand
Operating Expenses 99.22 Million 86.51 Million 91.66 Million 48.97 Million 37.03 Million 38.41 Million
Selling, General and Administrative Expenses 16 Million 15.26 Million 13.3 Million 10.33 Million 14.52 Million 13.58 Million
Research and Development Expenses 83.21 Million 71.25 Million 61.11 Million 38.63 Million 22.51 Million 24.82 Million
Other Expenses - -1.96 Million 17.25 Million 4.89 Million 1.99 Million 28 Thousand
Cost and Expenses 99.22 Million 86.51 Million 91.66 Million 48.97 Million 37.03 Million 38.41 Million
Operating Income -99.22 Million -119.48 Million -91.66 Million -48.97 Million -37.03 Million -42.02 Million
Interest Expense - 1.04 Million - - 107 Thousand -
Income Tax Expense - 33.88 Million -151 Thousand -58 Thousand -107 Thousand 549 Thousand
Earnings before Tax -93.61 Million -120.4 Million -92.94 Million -44.01 Million -34.93 Million -41.47 Million
Net Income -93.61 Million -154.29 Million -92.79 Million -43.95 Million -34.82 Million -41.47 Million
Earnings Per Share Basic -2.11 -4.85 -3.92 -2.81 -4.51 -39.16
Earnings Per Share Diluted -2.11 -4.85 -3.92 -2.81 -4.51 -39.16
Weighted Average Shares Outstanding 44.32 Million 31.81 Million 23.65 Million 15.66 Million 7.72 Million 1.05 Million
Weighted Average Shares Outstanding (Diluted) 44.32 Million 31.81 Million 23.65 Million 15.66 Million 7.72 Million 1.05 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -99.11 Million -120.33 Million -92.86 Million -48.93 Million -36.98 Million -15.14 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts